Tigecycline attenuates polymorphonuclear leukocyte (PMN) receptors but not functions

Are Naess1, Hristina Andreeva, Steinar Sørnes

  • 1Institute of Medicine, University of Bergen, Haukeland University Hospital, N-5021Bergen, Norway.

Insights

Tigecycline slightly reduced immune cell receptors at high doses but did not impact Staphylococcus aureus phagocytosis or oxidative burst in polymorphonuclear leukocytes (PMNs). This antibiotic maintains crucial immune cell functions.

Area of Science:

  • Immunology
  • Pharmacology
  • Microbiology

Background:

  • Tigecycline achieves high intracellular concentrations within polymorphonuclear leukocytes (PMNs).
  • Understanding tigecycline's impact on PMN function is crucial for its clinical application.
  • PMNs play a vital role in the innate immune response against bacterial infections.

Purpose of the Study:

  • To evaluate the effects of tigecycline on human PMN receptors and functions.
  • To assess if tigecycline influences phagocytosis and oxidative burst induced by Staphylococcus aureus.

Main Methods:

  • Human PMNs were incubated with varying concentrations of tigecycline (0.1 to 100 mg L-1).
  • Flow cytometry was used to measure PMN Fcγ receptors (CD16, CD32) and complement receptors (CD11b, CD35).
  • Phagocytosis and oxidative burst assays using Staphylococcus aureus were performed.

Main Results:

  • Tigecycline caused minor, concentration-dependent decreases in the density of complement receptors CD11b and CD35, and Fcγ receptors CD16 and CD32.
  • The percentage of receptor-bearing cells remained largely unaffected, except for a slight reduction in CD16 positive cells at high concentrations.
  • Tigecycline did not alter phagocytosis or oxidative burst activity of PMNs against Staphylococcus aureus.

Conclusions:

  • Tigecycline is associated with reduced PMN complement and Fcγ receptor density, particularly at high concentrations.
  • These minor changes in receptor density did not significantly impair PMN phagocytosis or oxidative burst functions.
  • Tigecycline appears to preserve key PMN functions essential for combating bacterial infections like those caused by Staphylococcus aureus.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...